Sign inSubscribe

target directory

alt 803 clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.

Validated reports

1

Directory type

target

Association rule

normalized field

NCT03381586
Source recordAI-normalized

QUILT-1.004: A Single Center, Open-label, Pharmacokinetic Study of Subcutaneous ALT-803

This study, conducted by Altor BioScience, evaluated the pharmacokinetics of ALT-803, a drug administered subcutaneously to healthy volunteers. The trial aimed to understand the drug's absorption, distribution, metabolism, and excretion characteristics.

AI analysis

Indication: Healthy

Modality: small molecule

Target: ALT-803

Sponsor: Altor BioScience

Source URL: ClinicalTrials.gov

Source updated: Mar 24, 2025

Ingested: May 23, 2026

Model: trialsignal-ai-v1

Validation: validated

Matched by target_normalized: ALT-803

View original source fields

Condition raw: Healthy

Condition normalized: Healthy

Modality raw: Healthy

Modality normalized: small molecule

Target raw: ALT-803

Target normalized: ALT-803

Open report